Our activity in the market this week involved 2 new trades, specifically 1 buys and 1 sells.
Whether you’re an investor or just interested in the stock market, our weekly Momentum Ranking report based on Andreas Clenow’s book Stocks on the Move is a must-read! Click here to access the latest data for week 39 and stay up-to-date on the top performers.
This Week’s Trading Activity
Welcome back to our ongoing series about momentum investing, inspired by Andreas Clenow’s book “Stocks On The Move.” This week, the S&P 500 has been above its 200-day moving average for 224 days. Our strategy follows a strict rule-based system, using the adjusted slope ranking to guide our investment choices.
Buys and Sells
This week saw a bit of action in our portfolio. We sold LMB as part of our strategy to keep only the highest-ranked stocks. While adjustments were made to existing holdings, the notable buy this week was PLTR. Palantir Technologies specializes in data analytics and is known for its role in offering data-centric solutions for various industries.
Despite new additions, a significant portion of our portfolio remains in cash reserves, aimed at mitigating risk during uncertain periods.
Summary
Our current portfolio is highly concentrated in cash to manage risks. Some of our top holdings include United Therapeutics (UTHR) and Corcept Therapeutics (CORT). Over the past 7 trading days, Texas Pacific Land (TPL) was our best performer with a gain of 17.69%. On the flip side, Halozyme Therapeutics (HALO) underperformed with a loss of 6.05%.
In summary, this week’s trading activity reflected our systematic approach to momentum investing. We sold LMB and took new positions in PLTR while largely maintaining cash reserves to hedge against volatility. We encourage you to share your thoughts or questions in the comments below—let’s keep the conversation going!
This week’s transactions:
-
Rebalanced / added:
- No positions were added to in this week!
-
Rebalanced / reduced:
- No positions were reduced in this week!
Index Distribution:
At the moment, we are holding mostly cash:
Current portfolio allocation:
Things are a bit quiet in the portfolio, mostly just cash and waiting for the right moment:
Weekly sector distribution:
Current portfolio (@finviz):
| Symbol | Name | Index | Sector | MC | Dist to 52w High | pct |
|---|---|---|---|---|---|---|
| cash | Cash | Cash | Cash | – | 191929 | 0.922 |
| UTHR | United Therapeutics Corp | S&P 400 | Healthcare | 15.92B | -2.28% | 0.015 |
| CORT | Corcept Therapeutics Inc | Barrons 400 | Healthcare | 4.61B | 0.77% | 0.015 |
| TPL | Texas Pacific Land Corporation | S&P 400 | Energy | 21.77B | -1.13% | 0.014 |
| HALO | Halozyme Therapeutics Inc. | S&P 400 | Healthcare | 7.15B | -13.84% | 0.011 |
| PLTR | Palantir Technologies Inc | S&P 500 | unknown | 82.99B | -2.96% | 0.01 |
| TBBK | Bancorp Inc. | Barrons 400 | Financial Services | 2.54B | -5.67% | 0.007 |
| LNTH | Lantheus Holdings Inc | S&P 400 | Healthcare | 7.77B | -11.84% | 0.006 |
As always, more trades next week!